Listeria: From Food Poisoning to Cancer Immunotherapy

Value of the Information & Strength of the Argument

The presentation provides valuable insights into the basic biology of Listeria and its translational applications. The argumentation is solid, built on decades of research and specific experimental evidence. Dr. Portnoy clearly explains complex concepts, such as the role of LLO in phagosomal escape and the importance of cytosolic detection for immune activation. He supports his claims with data from genetic screens and biochemical analyses, making a compelling case for the use of Listeria in immunotherapy. The logical progression from basic science to clinical application is well-structured and persuasive.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, as Dr. Portnoy is a leading researcher in the field with over 100 publications. He references specific studies and experimental results, though he does not cite external sources in the talk. The title accurately reflects the content, covering both the pathogenic and therapeutic aspects. The presentation is suitable for a general audience with some scientific background, but it does not oversimplify the science. The talk is based on peer-reviewed research and his own laboratory’s findings, ensuring reliability.

The title accurately reflects the content, covering both the pathogenic nature of Listeria and its potential in cancer immunotherapy.

8/10

Presentation by a leading expert with extensive research background, based on peer-reviewed studies and direct laboratory findings. Some claims are simplified for a general audience, but the core science is accurate and well-supported.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 02:00Introduction to infectious disease burden and the 'big three' pathogens.
• 05:00Overview of Listeria as a foodborne pathogen and its characteristics.
• 10:00Cellular biology of Listeria: phagosomal escape, actin-based motility, and cell-to-cell spread.
• 15:00Role of listeriolysin O (LLO) and its regulation; experiments with perfringolysin O.
• 20:00Immunity to Listeria: live infection induces protective T cells, killed bacteria do not.
• 25:00Host cell detection of cytosolic bacteria via cyclic di-AMP and interferon response.
• 30:00Development of Listeria as a vaccine vector for cancer and infectious diseases.
• 35:00Discussion of ongoing clinical trials and potential of Listeria-based immunotherapy.

• Coalition for the Life Sciences — Video source

• Portnoy Lab at UC Berkeley — Research on Listeria and host-pathogen interactions.